150 related articles for article (PubMed ID: 8412206)
21. Chemopreventive activity of oltipraz.
Clapper ML
Pharmacol Ther; 1998 Apr; 78(1):17-27. PubMed ID: 9593327
[TBL] [Abstract][Full Text] [Related]
22. Dithiolethiones for cancer chemoprevention: where do we stand?
Zhang Y; Munday R
Mol Cancer Ther; 2008 Nov; 7(11):3470-9. PubMed ID: 19001432
[TBL] [Abstract][Full Text] [Related]
23. Levels of aflatoxin-albumin biomarkers in rat plasma are modulated by both long-term and transient interventions with oltipraz.
Egner PA; Gange SJ; Dolan PM; Groopman JD; Muñoz A; Kensler TW
Carcinogenesis; 1995 Aug; 16(8):1769-73. PubMed ID: 7634402
[TBL] [Abstract][Full Text] [Related]
24. Identification of dithiolethiones with better chemopreventive properties than oltipraz.
Maxuitenko YY; Libby AH; Joyner HH; Curphey TJ; MacMillan DL; Kensler TW; Roebuck BD
Carcinogenesis; 1998 Sep; 19(9):1609-15. PubMed ID: 9771932
[TBL] [Abstract][Full Text] [Related]
25. Clinical pharmacology studies of oltipraz--a potential chemopreventive agent.
Dimitrov NV; Bennett JL; McMillan J; Perloff M; Leece CM; Malone W
Invest New Drugs; 1992 Nov; 10(4):289-98. PubMed ID: 1487402
[TBL] [Abstract][Full Text] [Related]
26. Chronic dosing of oltipraz in people at increased risk for colorectal cancer.
Szarka CE; Yao KS; Pfeiffer GR; Balshem AM; Litwin S; Frucht H; Goosenberg EB; Engstrom PF; Clapper ML; O'Dwyer PJ
Cancer Detect Prev; 2001; 25(4):352-61. PubMed ID: 11531012
[TBL] [Abstract][Full Text] [Related]
27. Structure-activity relationships in the induction of Phase II enzymes by derivatives of 3H-1,2-dithiole-3-thione in rats.
Munday R; Zhang Y; Munday CM; Li J
Chem Biol Interact; 2006 Mar; 160(2):115-22. PubMed ID: 16458871
[TBL] [Abstract][Full Text] [Related]
28. Safety and efficacy of weekly oral oltipraz in chronic smokers.
Kelley MJ; Glaser EM; Herndon JE; Becker F; Bhagat R; Zhang YJ; Santella RM; Carmella SG; Hecht SS; Gallot L; Schilder L; Crowell JA; Perloff M; Folz RJ; Bergan RC
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):892-9. PubMed ID: 15824161
[TBL] [Abstract][Full Text] [Related]
29. Cellular kinetics of induction by oltipraz and its keto derivative of detoxication enzymes in human colon adenocarcinoma cells.
O'Dwyer PJ; Clayton M; Halbherr T; Myers CB; Yao Ks
Clin Cancer Res; 1997 May; 3(5):783-91. PubMed ID: 9815750
[TBL] [Abstract][Full Text] [Related]
30. Evidence for thiol-dependent production of oxygen radicals by 4-methyl-5-pyrazinyl-3H-1,2-dithiole-3-thione (oltipraz) and 3H-1,2-dithiole-3-thione: possible relevance to the anticarcinogenic properties of 1,2-dithiole-3-thiones.
Kim W; Gates KS
Chem Res Toxicol; 1997 Mar; 10(3):296-301. PubMed ID: 9084909
[TBL] [Abstract][Full Text] [Related]
31. Protection of retinal pigment epithelial cells from oxidative damage by oltipraz, a cancer chemopreventive agent.
Nelson KC; Armstrong JS; Moriarty S; Cai J; Wu MW; Sternberg P; Jones DP
Invest Ophthalmol Vis Sci; 2002 Nov; 43(11):3550-4. PubMed ID: 12407167
[TBL] [Abstract][Full Text] [Related]
32. Oltipraz chemoprevention trial in Qidong, Jiangsu Province, People's Republic of China.
Zhang BC; Zhu YR; Wang JB; Wu Y; Zhang QN; Qian GS; Kuang SY; Li YF; Fang X; Yu LY; De Flora S; Jacobson LP; Zarba A; Egner PA; He X; Wang JS; Chen B; Enger CL; Davidson NE; Gordon GB; Gorman MB; Prochaska HJ; Groopman JD; Muñoz A; Kensler TW
J Cell Biochem Suppl; 1997; 28-29():166-73. PubMed ID: 9589363
[TBL] [Abstract][Full Text] [Related]
33. Role of transcription factor Nrf2 in the induction of hepatic phase 2 and antioxidative enzymes in vivo by the cancer chemoprotective agent, 3H-1, 2-dimethiole-3-thione.
Kwak MK; Itoh K; Yamamoto M; Sutter TR; Kensler TW
Mol Med; 2001 Feb; 7(2):135-45. PubMed ID: 11471548
[TBL] [Abstract][Full Text] [Related]
34. Effects of dietary oltipraz and ethoxyquin on aflatoxin B1 biotransformation in non-human primates.
Bammler TK; Slone DH; Eaton DL
Toxicol Sci; 2000 Mar; 54(1):30-41. PubMed ID: 10746929
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the post-initiation effects of oltipraz on aflatoxin B1-induced preneoplastic foci in a rat model of hepatic tumorigenesis.
Maxuitenko YY; MacMillan DL; Kensler TW; Roebuck BD
Carcinogenesis; 1993 Nov; 14(11):2423-5. PubMed ID: 8242875
[TBL] [Abstract][Full Text] [Related]
36. Protection by 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) against the hepatotoxicity of aflatoxin B1 in the rat.
Liu YL; Roebuck BD; Yager JD; Groopman JD; Kensler TW
Toxicol Appl Pharmacol; 1988 May; 93(3):442-51. PubMed ID: 3130679
[TBL] [Abstract][Full Text] [Related]
37. Inhibition by dietary oltipraz of experimental intestinal carcinogenesis induced by azoxymethane in male F344 rats.
Rao CV; Tokomo K; Kelloff G; Reddy BS
Carcinogenesis; 1991 Jun; 12(6):1051-5. PubMed ID: 2044183
[TBL] [Abstract][Full Text] [Related]
38. Chronic toxicity studies of 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione, a potential chemopreventive agent.
Crowell JA; Page JG; Rodman LE; Heath JE; Goldenthal EI; Hall LB; Kelloff GJ
Fundam Appl Toxicol; 1997 Jan; 35(1):9-21. PubMed ID: 9024669
[TBL] [Abstract][Full Text] [Related]
39. Reduction of aflatoxin B(1) adduct biomarkers by oltipraz in the tree shrew (Tupaia belangeri chinensis).
Li Y; Su J; Qin L; Egner PA; Wang J; Groopman JD; Kensler TW; Roebuck BD
Cancer Lett; 2000 Jun; 154(1):79-83. PubMed ID: 10799742
[TBL] [Abstract][Full Text] [Related]
40. Chemopreventive activity of Oltipraz against N-nitrosobis(2-oxopropyl)amine (BOP)-induced ductal pancreatic carcinoma development and effects on survival of Syrian golden hamsters.
Clapper ML; Wood M; Leahy K; Lang D; Miknyoczki S; Ruggeri BA
Carcinogenesis; 1995 Sep; 16(9):2159-65. PubMed ID: 7554069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
